Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-PC-B70M in mild to moderate Alzheimer's disease
NCT01249196Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- May 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SK-PC-B70M in Alzheimer's disease (AD), sponsored by SK Chemicals. Started May 2010; status: completed.
02
Drugs
SK-PC-B70M
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01249196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01249196.